Adicon Holdings (HKSE:09860) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Adicon Holdings Dividend Payout Ratio?

Adicon Holdings's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Adicon Holdings's Dividend Payout Ratio or its related term are showing as below:

HKSE:09860's Dividend Payout Ratio is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 0.4
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-06), the Dividend Yield % of Adicon Holdings is 0.00%.

Adicon Holdings's Dividends per Share for the months ended in Dec. 2023 was HK$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Adicon Holdings Dividend Payout Ratio Historical Data

The historical data trend for Adicon Holdings's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicon Holdings Dividend Payout Ratio Chart

Adicon Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Adicon Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Adicon Holdings's Dividend Payout Ratio

For the Diagnostics & Research subindustry, Adicon Holdings's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adicon Holdings's Dividend Payout Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Adicon Holdings's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Adicon Holdings's Dividend Payout Ratio falls into.

Adicon Holdings Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Adicon Holdings's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0	/	0.499
	=	0.00

Adicon Holdings's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	0.253
	=	0.00

Adicon Holdings (HKSE:09860) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Adicon Holdings Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Adicon Holdings's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Adicon Holdings (HKSE:09860) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (HKSE:09860) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

ADCNF:USA

Address

No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN

Website

https://www.adicon.com.cn

Adicon Holdings Ltd is one of the top three independent clinical laboratory or ICL, service providers in China. The company offers comprehensive and best-in-class testing services primarily to hospitals and health check centers through an integrated network of 33 self-operated laboratories across China. The high quality of its services is backed by its strong performance in terms of international accreditation and comprehensive testing menu. Its testing portfolio consists of over 4,000 medical diagnostic tests, including over 1,700 routine tests and over 2,300 esoteric tests. It has three major service platforms. Among them, the inspection service platform consists of clinical, pathology, reproductive genetic, genetic, and mass spectrometry laboratories.

Executives

Cap V General Partner, L.p.	2201 Interest of corporation controlled by you
Cap V, L.l.c.	2201 Interest of corporation controlled by you
Carlyle Asia Partners V, L.p.	2201 Interest of corporation controlled by you
Carlyle Holdings Ii Gp L.l.c.	2201 Interest of corporation controlled by you
Carlyle Holdings Ii L.l.c.	2201 Interest of corporation controlled by you
Cg Subsidiary Holdings L.l.c.	2201 Interest of corporation controlled by you
Pearl Group Limited	2101 Beneficial owner
Tc Group Cayman Investment Holdings L.p.	2201 Interest of corporation controlled by you
Tc Group Cayman Investment Holdings Sub L.p.	2201 Interest of corporation controlled by you
The Carlyle Group Inc.	2201 Interest of corporation controlled by you
Lin Feng
Mega Stream Limited
Trident Trust Company (hk) Limited	2301 Trustee
Ingenuity Capital Holdings Limited	2201 Interest of corporation controlled by you
Corelink Group Limited

Adicon Holdings (HKSE:09860) Headlines

No Headlines